Public Profile

Trevena, Inc.

Trevena, Inc., a biopharmaceutical company headquartered in the United States, is at the forefront of developing innovative therapies for patients with serious medical conditions. Founded in 2007, Trevena has made significant strides in the industry, particularly in the areas of pain management and central nervous system disorders. The company is renowned for its unique approach to drug development, focusing on G protein-coupled receptors (GPCRs) to create safer and more effective treatments. Trevena's flagship product, Olinvyk (oliceridine), exemplifies this commitment, offering a novel option for intravenous pain relief. With a strong market position and a dedication to advancing healthcare, Trevena continues to achieve notable milestones, solidifying its reputation as a leader in the biopharmaceutical sector.

DitchCarbon Score

How does Trevena, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

19

Industry Benchmark

Trevena, Inc.'s score of 18 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Let us know if this data was useful to you

Trevena, Inc.'s reported carbon emissions

Trevena, Inc., headquartered in the US, currently does not have available carbon emissions data or specific reduction targets. As such, there are no reported figures for their Scope 1, 2, or 3 emissions. The company has not publicly committed to any climate pledges or initiatives aimed at reducing carbon emissions. In the absence of specific data, it is unclear how Trevena, Inc. is addressing climate change or its carbon footprint within the pharmaceutical industry context.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Trevena, Inc.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Trevena, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Trevena, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Pacira Pharmaceuticals, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Heron Therapeutics, Inc.

US
Health and social work services (85)
Updated 2 days ago

Baudax Bio, Inc.

US
Health and social work services (85)
Updated 2 days ago

Johnson And Johnson

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Cumberland Pharmaceuticals Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Sandoz Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers